| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |